IOVA - What's Going On With Iovance Biotherapeutics Stock? | Benzinga
Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares are trading higher Tuesday amid several developments. Here’s a look at what you need to know.
What To Know: WuXi Advanced Therapies announced Tuesday that the U.S. Food and Drug Administration (FDA) approved it to begin analytical testing and manufacturing of AMTAGVI for Iovance Biotherapeutics at its Philadelphia site. AMTAGVI received accelerated approval of its BLA on Feb. 16.
WuXi’s site is set to become the first third-party contract testing, development and manufacturing organization to ...